Key result
Genetic analysis reveals ~44% overlap between PCOS and T2D, identifying several novel risk variants.
Why the study?
The etiology of polycystic ovary syndrome remains incomplete, and there is potential genetic correlation between PCOS and type 2 diabetes that may enhance understanding of PCOS.
Observational (n=935,394)
The study identifies a shared genetic architecture between PCOS and T2D, revealing 9 novel genetic variants associated with PCOS that may involve lipid metabolism, immune response, and insulin signaling.
Answers are grounded in this paper and cite their sources.
Supports shared genetic risk between PCOS and T2D; leaves open clinical utility pending validation.
Genome-wide association studies (GWAS) have identified several common variants associated with polycystic ovary syndrome (PCOS). However, the etiology behind PCOS remains incomplete. Available evidence suggests a potential genetic correlation between PCOS and type 2 diabetes (T2D). The publicly available data may provide an opportunity to enhance the understanding of the PCOS etiology. Here, we quantified the polygenic overlap between PCOS and T2D using summary statistics of PCOS and T2D and then identified the novel genetic variants associated with PCOS behind this phenotypic association. A bivariate causal mixture model (MiXeR model) found a moderate genetic overlap between PCOS and T2D (Dice coefficient = 44.1% and after adjusting for body mass index, 32.1%). The conditional/conjunctional false discovery rate method identified 11 potential risk variants of PCOS conditional on associations with T2D, 9 of which were novel and 6 of which were jointly associated with two phenotypes. The functional annotation of these genetic variants supports a significant role for genes involved in lipid metabolism, immune response, and the insulin signaling pathway. An expression quantitative trait locus functionality analysis successfully repeated that 5 loci were significantly associated with the expression of candidate genes in many tissues, including the whole blood, subcutaneous adipose, adrenal gland, and cerebellum. We found that SCN2A gene is co-localized with PCOS in subcutaneous adipose using GWAS-eQTL co-localization analyses. A total of 11 candidate genes were differentially expressed in multiple tissues of the PCOS samples. These findings provide a new understanding of the shared genetic architecture between PCOS and T2D and the underlying molecular genetic mechanism of PCOS.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) conducted an observational in Polycystic ovary syndrome and Type 2 diabetes (n=935,394). Shared genetic variants (SNPs) vs. Unexposed/reference alleles was evaluated on Polygenic overlap between PCOS and T2D (Dice coefficient 44.1%). A bivariate causal mixture model revealed a moderate genetic overlap between PCOS and T2D with a Dice coefficient of 44.1%, leading to the identification of 11 potential risk variants for PCOS, 9 of which were novel.
Synapse has enriched 10 related papers. Consider them for comparative context: